Mark Jason Roschewski from 15204 Spring Meadows Dr, Germantown, MD 20874, age 49, Phone: 3017173122

Mark Roschewski Phones & Addresses

15204 Spring Meadows Dr, Germantown, MD 20874 • 3017173122
Darnestown, MD
Bethesda, MD
Evans, GA
3040 Davis Rd, Fairbanks, AK 99709
Augusta, GA
Notre Dame, IN
Omaha, NE
15204 Spring Meadows Dr, Germantown, MD 20874 • 3016563449

Work

Company:

WALTER REED ARMY MEDICAL CENTER
Address:

6900 Georgia Ave Nw, Washington, DC 20307
Phones:

2027826765 2027829278

Education

School / High School:

University of Nebraska / College of Medicine
2001

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate:

Hematology, 2009

Specialities

Hematology • Medical Oncology • Oncology

Name / Title

Company / Classification

Phones & Addresses

Mark Jason Roschewski

Mark Roschewski MD
Internist

6900 Georgia Ave NW, Washington, DC 20307
2027824950

Medicine Doctors

Dr. Mark J Roschewski, Sioux Falls SD - MD (Doctor of Medicine)

view source

Specialties:

Hematology
Medical Oncology
Oncology

Age:

Address:

3720 W 69Th St, Sioux Falls, SD 57108

6900 Georgia Ave Nw, Washington, DC 20307
2027824950 (Phone)

WALTER REED ARMY MEDICAL CENTER
6900 Georgia Ave Nw, Washington, DC 20307
2027826765 (Phone), 2027829278 (Fax)

Certifications:

Hematology, 2009
Internal Medicine, 2004
Medical Oncology, 2010

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
University of Nebraska / College of Medicine
Graduated: 2001

Mark Jason Roschewski

view source

Specialties:

Internal Medicine
Hematology
Medical Oncology

Education:

University of Nebraska (2001)

Googleplus

Mark Roschewski

Youtube

Acalabrutinib and AZD9150 combination for the...

In this video, Mark Roschewski, MD, National Cancer Institute, Bethesd...

Duration:

1m 38s

An update on MRD assessment and novel techniq...

In this video, Mark Roschewski, MD, National Cancer Institute, Bethesd...

Duration:

2m 35s

Using ctDNA assays to monitor clonal evolutio...

Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, reports ...

Duration:

2m 58s

Acalabrutinib window prior to frontline thera...

Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, reports ...

Duration:

2m 43s

Dr. Roschewski on the Rationale of Liquid Bio...

Mark J. Roschewski, MD, staff clinician, Lymphoid Malignancies Section...

Duration:

1m 6s

An analysis of the risk factors associated wi...

In this video, Mark Roschewski, MD, National Cancer Institute, Bethesd...

Duration:

3m 10s

Safety and efficacy of escalating doses of th...

Dr Mark Roschewski speaks to ecancer at the 2019 European Hematology A...

Duration:

5m 27s

Oncology drugs for treatment of severe Covid 19

... interviews Mark Roschewski, M.D. Dr. Roschewski is a clinician-sci...

Duration:

40m 15s

News

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma

view source

NCIs Center for Cancer Research investigators Wyndham H. Wilson, M.D., Ph.D., Mark Roschewski, M.D., and Louis M. Staudt, M.D., Ph.D., co-led the study with Dr. Melani. Investigators from NIHs National Center for Advancing Translational Sciences and other institutions contributed to the study.
Date: Jun 20, 2024
Category: Health
Source: Google

Facebook

Mark Roschewski

view source

Friends:

Keith Weinhold, Dan Hermsen, Gretchen Kristine Langvardt Stelzer, Stacey Lane